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and air from the cardiac chambers.2 Several treatment
modalities were suggested for massive arterial air
embolism during CPB,3,4 but hyperbaric oxygen (HBO)
is the main therapy for massive arterial air embolism
from any cause.5 In this report, we review our experi-
ence with HBO therapy for massive arterial air
embolism after cardiac operations.
Methods
The Israel Naval Medical Institute (INMI) is the only refer-
ral hyperbaric center in Israel for acute care patients. We
reviewed the records of all the patients who were admitted for
HBO therapy after sustaining massive arterial air embolism
during cardiac operations between 1985 and 1998. Collected
data included age, gender, year of operation, surgical proce-
dure, delay from operation to HBO therapy, and neurologic
status at discharge from the hospital. The diagnosis of sys-
temic arterial air embolism during CPB was made by the sur-
gical team. Immediate treatment strategies and the decision
whether to consult the INMI was also made by the same team.
M assive arterial air embolism during cardiac opera-tions and cardiopulmonary bypass (CPB) is a rare
event that is associated with high morbidity and mortal-
ity rates.1 The presence of air bubbles in the cerebral
arteries causes an abrupt decrease of blood flow in areas
supplied by these vessels. The most common causes for
massive arterial air embolism during cardiac operations
are low oxygenator blood level, reversal of vent flow,
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In all cases in which the INMI was consulted, we recom-
mended an immediate transfer for HBO therapy, regardless of
the time delay. Patients were transferred by an intensive care
ground ambulance and were admitted at the surgical intensive
cardiac care unit of the nearby hospital. They were trans-
ferred for HBO therapy as soon as possible thereafter.
Monitoring during the HBO session included a 3-lead elec-
trocardiogram, body temperature, pulse oximetry, end-tidal
carbon dioxide, invasive blood pressure, and central venous
or left atrial pressure. Arterial blood gas analysis was done at
least once for every HBO session. Inotropic medications,
vasodilators, crystalloids, colloids, red blood cells, and blood
products were administered as needed. Neurologic status was
evaluated by the patients’ surgical service. A neurologist was
consulted as needed. The end point was the neurologic status
at discharge from the hospital.
Statistical analysis. Results are reported as mean ± SD.
One-way analysis of variance and Tukey tests compared the
mean differences in the time delay from the operation to HBO
among the groups. The nonparametric correlation coefficient
Kendall’s tau (t ) with exact 2-sided P value was used to
examine the association between outcome and treatment
delay (STATISTICA for Windows, Release 4.3 B; StatSoft,
Inc, Tulsa, Okla).
Results
Seventeen patient records were available for review.
Patients were transferred from 5 cardiac surgical cen-
ters. Age, gender, year of operation, and the surgical
procedure are listed in Table I. Fourteen patients (82%)
were adults with ischemic and/or valvular heart dis-
ease, and 3 patients (18%) were children with congen-
ital heart disease. All patients were neurologically
intact before the operation. Neurologic status before
HBO treatment could not be assessed because of the
effect of anesthetics, sedatives, opioids, and, in some
cases, muscle relaxants. Mean age was 55 ± 26 years
(range, 2.5-79 years). All patients underwent a cardiac
operation with CPB. In all cases, systemic arterial air
embolism was either suspected or clearly diagnosed
while the CPB circuit was running. Immediate man-
agement included stopping pump flow, head-down
position, evacuation of air, hypothermia, high pump
flow after resumption of circulation, and, in few cases,
glucocorticoid administration. Retrograde perfusion
was not performed. In several occasions, the surgical
team elected not to consult the INMI immediately but
to treat the patient in the intensive care unit first. The
delay from the end of the operation to the beginning of
HBO therapy was 9.6 ± 7.4 hours (range, 1-20 hours;
Table II). All patients were intubated and mechanically
ventilated on arrival to the hyperbaric center. Sixteen
patients (94.1%) were treated according to the US
Navy Table 6A.6 One patient (5.9%) received hyper-
baric therapy at 2.8 atmospheric absolute for 90 min-
utes. Three patients received additional hyperbaric ses-
sions. Eight patients (47.1%) had a complete
neurologic recovery; 6 patients (35.3%) remained
unconscious at discharge, and 3 patients (17.6%) died
during the same hospitalization; 1 of the deaths
Table I. Demographic data, year of the operation, and
surgical procedure 
Age Year of Surgical 
Patient (y) Gender operation procedure
1 73 M 1998 CABG
2 4 F 1990 Closure of ASD
3 62 F 1993 CABG
4 70 F 1991 AVR
5 2.5 M 1996 Repair of TOF
6 77 M 1996 CABG
7 65 M 1996 MVR
8 52 M 1992 CABG
9 75 M 1996 CABG
10 71 F 1994 AVR
11 4 F 1993 Repair of TOF
12 79 M 1997 CABG + AVR
13 53 M 1989 CABG
14 62 F 1985 CABG + CEA
15 57 M 1988 CABG + MVR
16 77 F 1993 CABG
17 55 M 1987 CABG
CABG, Coronary artery bypass grafting; ASD, atrial septal defect; AVR, aortic
valve replacement; TOF, tetralogy of Fallot; MVR, mitral valve replacement;
CEA, carotid endarterectomy.
Table II. Delay from the end of the operation to the
beginning of HBO therapy and neurologic outcome
Delay from operation Neurologic 
Patient to HBO (h) outcome
1 1 Recovery
2 2 Recovery
3 2.5 Recovery
4 3 Recovery
5 3 Recovery
6 3.3 Recovery
7 5 Recovery
8 5 Disability
9 5 Disability
10 9.5 Disability
11 12 Recovery
12 16 Death
13 17 Disability
14 18 Death
15 20 Disability
16 20 Disability
17 20 Death
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occurred while the patient was being treated in the
hyperbaric chamber. The delay from the operation to
HBO was 4.0 ± 3.4 hours (range, 1-12 hours) for
patients who had a full neurologic recovery, 12.8 ± 7.1
hours (range, 5-20 hours) for patients with severe neu-
rologic disability, and 18.0 ± 2.0 hours (range, 16-20
hours) for patients who died (1-way analysis of vari-
ance; P = .002). The source of variance among the
groups mainly resulted from the shorter delay for
patients who experienced complete recovery compared
with the other 2 groups (Tukey test). All 5 patients who
were treated within 3 hours from the operation and
50% (2 of 4) of those patients who were treated 3 to 5
hours from the operation had a full neurologic recov-
ery. With a delay of 9 to 20 hours, only 1 of 8 patients
had a full neurologic recovery. The association
between outcome and treatment delay was found to be
statistically significant ( t = 0.65, with exact 2-sided
P = .0007).
Discussion
Systemic arterial air embolism is a rare but devastat-
ing complication of cardiac operation with CPB. Air
bubbles obstructing the cerebral arteries can cause
severe neurologic disability and death.2 There is no
unanimous approach for the best medical management
of the patient who experiences a sudden onset of sys-
temic arterial air embolism during CPB. Although
many management options have been suggested in the
literature,7,8 HBO remains the main treatment for air
embolism from any cause.5,9 Air bubbles in the sys-
temic circulation cause an immediate mechanical
obstruction to blood flow, followed by a local inflam-
matory response, which may aggravate the damage.10
Although micro air embolism during CPB is common,
macroembolism is rare and largely underdiagnosed,
undertreated, and underreported.3 The incidence is esti-
mated to be 0.1%1 but may have been decreased since
that report, because of improved surgical and pump
techniques. The favorable effects of HBO in the treat-
ment of systemic air embolism were reported in detail.9
In brief, according to Boyle’s law, a 6-fold increase in
the atmospheric pressure will decrease the gas-bubble
volume and diameter to 16.6% and 55% of its original
size, respectively. Mechanical ventilation (inspired
oxygen fraction = 1.0) minimizes the partial pressure
of nitrogen and provides a large pressure gradient for
N2 absorption from the bubble. Decreased PaN2 has
been shown to accelerate bubble absorption.11 When
oxygen is administered at a partial pressure of 3 atmos-
pheres absolute, 6 mL of oxygen is dissolved in 100
mL of blood, an amount that is enough for the tissue
metabolism at rest, without oxygen carried by hemo-
globin. Oxygen diffusion distance and tissue oxygen
tension are also increased.12 HBO induces cerebral
vasoconstriction and decreases intracranial pressure.13
It may also inhibit the persistent adherence of leuko-
cytes to cerebral endothelium.14 In this report, we
found that a shorter delay from the operation to HBO
therapy, in patients with massive arterial air embolism,
was associated with a better neurologic outcome.
Similar results were reported by Murphy and col-
leagues,15 but their study lacks statistical analysis. It
must be stressed, however, that our retrospective study
does not provide enough data to support any specific
time frame for HBO therapy in these patients. “The
sooner the better” seems to be the rational approach.
All patients were treated before any neurologic assess-
ment was possible, so evaluation of improvement could
not be performed. Inspection is not recommended if the
patient spontaneously regains consciousness when
massive arterial air embolism is suspected or clearly
diagnosed during the operation. The approach may
cause unnecessary delay and decrease the likelihood of
neurologic recovery. We believe that a patient experi-
encing intraoperative air embolism should be treated by
HBO as soon as possible. The nearby hyperbaric facil-
ity, adequately staffed and equipped for the care of crit-
ically ill patients, should be consulted as soon as the
diagnosis is established, and transport arrangements
should be made during the last part of the surgical pro-
cedure. When massive arterial air embolism is diag-
nosed during the operation, radiologic studies of the
brain provide very little information and may cause an
unnecessary delay of treatment.16 In the different situ-
ation, at which a neurologic deficit is diagnosed the
first time in the intensive care unit, but the cause is
uncertain, radiologic study will probably be the next
step. Macroemboli were found in the brain several
hours17 and even days after an embolic event.18 De-
layed treatment with HBO for systemic air embolism
was reported,19 including cases of cardiac opera-
tions,20,21 and recovery might be achieved. Therefore
HBO therapy should be given even after a long delay.
The exact limit of this delay is unknown.
In summary, HBO is the specific treatment for mas-
sive arterial air embolism during cardiac operations. It
should be administered as soon as possible after the
end of the operation.
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